Oppenheimer Upgrades Arch Chemicals (ARJ) to Outperform
More News related to ARJ
- Arch Chemicals (ARJ) Tops Q3 EPS by 11c; Issues Mixed Guidance for Q4 and FY09
- Arch Chemicals Reports Third Quarter 2009 Earnings and Narrows Its Full-Year 2009 Earnings Guidance
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Arch Chemicals (ARJ) Declares $0.20 Dividend; 2.8% Yield
- Arch Chemicals, Inc. Declares Quarterly Dividend
More News related to Upgrades
- Canaccord Adams Upgrades Open Text (OTEX) to Buy; Raises Estimates & PT
- Stephens & Co Upgrades Aeropostale (ARO) to Overweight
- McAdams Wright Ragen Upgrades Zumiez (ZUMZ) to Buy
- Dahlman Rose Upgrades Intrepid Potash (IPI) to Hold
- Shares of LeapFrog (LF) Rallying Amid Stifel Upgrade
Oppenheimer upgrades Arch Chemicals (NYSE: ARJ) from Market Perform to Outperform. Price target $32.
Arch Chemicals, Inc. (Arch) is a global biocides company. The Company provides chemistry-based and related solutions to selectively destroy and control the growth of harmful microbes.
Related Categories
UpgradesStocks Mentioned
-0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
